<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Bone_Therapeutics_SA</id>
	<title>Bone Therapeutics SA - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Bone_Therapeutics_SA"/>
	<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Bone_Therapeutics_SA&amp;action=history"/>
	<updated>2026-05-27T23:27:21Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.5</generator>
	<entry>
		<id>https://stockhub.co/index.php?title=Bone_Therapeutics_SA&amp;diff=56822&amp;oldid=prev</id>
		<title>&gt;Nick: Created page with &quot;== Summary&lt;ref&gt;Source: Yahoo Finance.&lt;/ref&gt; ==  Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee...&quot;</title>
		<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Bone_Therapeutics_SA&amp;diff=56822&amp;oldid=prev"/>
		<updated>2022-08-21T23:03:25Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==  Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.&lt;br /&gt;
&lt;br /&gt;
== References and notes == &lt;br /&gt;
[[Category:Thesis]]&lt;br /&gt;
__INDEX__&lt;/div&gt;</summary>
		<author><name>&gt;Nick</name></author>
	</entry>
</feed>